Experimental results showed that HMSN-ISO@ProA-PD-L1 Ab nanoparticles inhibited the growth of hepatocellular carcinoma cells (Hepa 1–6 graft tumors) better than that of the groups treated with PD-L1 antibody or ISO alone. Here, CD274 is linked to hepatocellular carcinoma.